Related Experiment Video
Updated: Apr 19, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Reference datasets for bioequivalence trials in a two-group parallel design
Anders Fuglsang1, Helmut Schütz, Detlew Labes
1Fuglsang Pharma, Hiort Lorenzens Vej 6c st. tv., 6100, Haderslev, Denmark, anfu@fuglsangpharma.com.
Abstract:
In order to help companies qualify and validate the software used to evaluate bioequivalence trials with two parallel treatment groups, this work aims to define datasets with known results. This paper puts a total 11 datasets into the public domain along with proposed consensus obtained via evaluations from six different software packages (R, SAS, WinNonlin, OpenOffice Calc, Kinetica, EquivTest). Insofar as possible, datasets were evaluated with and without the assumption of equal variances for the construction of a 90% confidence interval. Not all software packages provide functionality for the assumption of unequal variances (EquivTest, Kinetica), and not all packages can handle datasets with more than 1000 subjects per group (WinNonlin). Where results could be obtained across all packages, one showed questionable results when datasets contained unequal group sizes (Kinetica). A proposal is made for the results that should be used as validation targets.
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence of Drugs: Drugs with Multiple Indications
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence studies: Biowaivers
Bioequivalence: Overview

